English | 日本語
1 TWEETS Evaluating the first drug to show improvement in subtype of autism
In an important test of one of the first drugs to target core symptoms of autism, researchers are undertaking a pilot clinical trial to evaluate insulin-like growth factor (IGF-1) in children who have SHANK3 deficiency (also known as 22q13 Deletion Syndro 55 weeks ago
Tweets |
About TweetbuzzTweetbuzz spotlights the hottest stories from Twitter.
At this moment, the must-read stories in the popular links are scattered across millions of news sites and blogs. That's far too much for any reader to follow.
Top Stories Right NowTop Stories Right Now(Science Daily:)Top Stories from Yesterday |